4:44 VIDEO "Taking Statin Drugs for Cholesterol " and Article, too.
Article excerpt:
. . . The problem with a statin is this: You don't want to choose a statin to lower a cholesterol number. To me, that's bad medicine and I'll tell you why. . . .
more video presentations by Dr. Diamond clearing up questions around this topic -
Posted by Keebler (Member # 12673) on :
- This classification of oils -from "vegetables" but really from seeds and put under high heat and industrial chemical treatment - not good for human consumption.
Hear how Tucker Goodrich cleared up many serious symptoms, especially in the gut, when he stopped all seed "vegetable" oils.
Anyone with pain, GI symptoms of all kinds and even mental concentration issues might find his own experiment encouraging. -
Posted by Blackstone (Member # 9453) on :
While its good to see some solid evidence of confirmation and always a positive to get the info out there to the masses, this isn't exactly a new concept.
I certainly hope the general medical community does not see this as a mind-blowing new development, as both previous study and common understanding of brain chemistry / function shows this makes sense.
Anticholinergics are medications that block the neurotransmitter acetylcholine. As there are receptors for this neurotransmitter in various places throughout the body (usually smooth-muscle related, like the bladder etc), it has sometimes been useful to add a medication to block them to alleviate various symptoms.
Unfortunately, this isn't as "targeted" as people thought and there are a lot of brain functions that require acetylcholine and choline in general. Think about the use of phos-chol supplements for neurological function etc. Thus, spending a long time messing with acetylcholine/choline function is likely to have a negative effect on the brain!
If nothing else, perhaps this will encourage physicians to avoid these types of drugs if at all possible seeking alternatives instead (note: many of the named drugs are older, cheaper medications; there are alternatives which I hope will be accessible financially), or in the case the drug is still the best option to look into the viability of supplementing choline-related support to potentially counteract the issue, taken up in greater quantities by the brain while still allowing the drugs to have their effects peripherally. Ideally, future studies can investigate the viability of such a protocol.